Bionano Genomics, Inc. — Director's Dealing 2020

Mar 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bionano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2019-03-01

Reporting Person: Ward Michael James (Former Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-01	Stock Option (Right to Buy)	$4.25	A	60000	Acquired	2029-02-28	Common Stock (60000)	Direct

Footnotes

F1: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of March 1, 2019 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.